These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14652236)

  • 1. The epigenome as a target for cancer chemoprevention.
    Kopelovich L; Crowell JA; Fay JR
    J Natl Cancer Inst; 2003 Dec; 95(23):1747-57. PubMed ID: 14652236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer chemoprevention by targeting the epigenome.
    Huang J; Plass C; Gerhauser C
    Curr Drug Targets; 2011 Dec; 12(13):1925-56. PubMed ID: 21158707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
    Rondelet G; Wouters J
    Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulators as therapeutic targets in prostate cancer.
    Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
    Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
    Oh S; Ko JY; Oh C; Yoo KH
    Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.
    Shankar E; Kanwal R; Candamo M; Gupta S
    Semin Cancer Biol; 2016 Oct; 40-41():82-99. PubMed ID: 27117759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of the cancer epigenome.
    Mabe NW; Perry JA; Malone CF; Stegmaier K
    Nat Cancer; 2024 Jun; 5(6):844-865. PubMed ID: 38937652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histone methyltransferases: a new class of therapeutic targets in cancer treatment?].
    Chaib H; Prébet T; Vey N; Collette Y
    Med Sci (Paris); 2011; 27(8-9):725-32. PubMed ID: 21880260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Therapeutics: A New Weapon in the War Against Cancer.
    Ahuja N; Sharma AR; Baylin SB
    Annu Rev Med; 2016; 67():73-89. PubMed ID: 26768237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the epigenome for the treatment and prevention of lung cancer.
    Schrump DS; Nguyen DM
    Semin Oncol; 2005 Oct; 32(5):488-502. PubMed ID: 16210090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors sit at crossroads of diet, aging, cancer.
    Hede K
    J Natl Cancer Inst; 2006 Mar; 98(6):377-9. PubMed ID: 16537828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.